30 Day FDA and ICH Drug Development Regulations - Day 15 Controlled Substances episode artwork

EPISODE · Jan 29, 2025 · 25 MIN

30 Day FDA and ICH Drug Development Regulations - Day 15 Controlled Substances

from Cannabinoid and Psychedelic Pharmacology and Drug Development

Dive into the complex world of controlled substances in this episode of Deep Dive. From the meticulous schedules of the Controlled Substances Act to the balancing act between regulation, research, and public safety, we explore how powerful drugs are developed, monitored, and controlled. Learn about the roles of the FDA and DEA, the challenges of manufacturing and distribution, and the growing interest in cannabinoids and psychedelics. We also tackle the vital topics of addiction, harm reduction, and equity, emphasizing the need for compassionate, evidence-based approaches. A thought-provoking look at an ever-evolving landscape!

Episode metadata supplied by the publisher feed · Published Jan 29, 2025

Embed this episode

NOW PLAYING

30 Day FDA and ICH Drug Development Regulations - Day 15 Controlled Substances

0:00 25:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 25 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 29, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!